FP0429 is a selective agonist for metabotropic glutamate receptors, acting as a full agonist at mGlu4 (EC50 = 48.3 μM) and a partial agonist at mGlu8 (EC50 = 56.2 μM); it is used as a pharmacological tool to study the roles of mGlu4 and mGlu8 receptors in neurological and psychiatric disorders.